Foster, 2016 - Google Patents
Optimizing the translational value of animal models of glomerulonephritis: insights from recent murine prototypesFoster, 2016
View PDF- Document ID
- 11795518958214243321
- Author
- Foster M
- Publication year
- Publication venue
- American Journal of Physiology-Renal Physiology
External Links
Snippet
Animal models are indispensable for the study of glomerulonephritis, a group of diseases that destroy kidneys but for which specific therapies do not yet exist. Novel interventions are urgently needed, but their rational design requires suitable in vivo platforms to identify and …
- 238000010171 animal model 0 title abstract description 23
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
- A01K67/027—New breeds of vertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Chen et al. | The role of NOD mice in type 1 diabetes research: lessons from the past and recommendations for the future | |
| Davis et al. | Inhibition of macrophage histone demethylase JMJD3 protects against abdominal aortic aneurysms | |
| Hudson et al. | Alport's syndrome, Goodpasture's syndrome, and type IV collagen | |
| Hu et al. | Investigation of the mechanism of action of alemtuzumab in a human CD52 transgenic mouse model | |
| Corthay et al. | Collagen-induced arthritis development requires αβ T cells but not γδ T cells: studies with T cell-deficient (TCR mutant) mice | |
| Ramanujam et al. | Selective blockade of BAFF for the prevention and treatment of systemic lupus erythematosus nephritis in NZM2410 mice | |
| Schubert et al. | Mast Cell Promotion of T Cell–Driven Antigen‐Induced Arthritis Despite Being Dispensable for Antibody‐Induced Arthritis in Which T Cells Are Bypassed | |
| Jennette et al. | Experimental models of vasculitis and glomerulonephritis induced by antineutrophil cytoplasmic autoantibodies | |
| Kinoshita et al. | Costimulation by B7-1 and B7-2 is required for autoimmune disease in MRL-Faslpr mice | |
| Henry et al. | Autoantigen-specific B-cell depletion overcomes failed immune tolerance in type 1 diabetes | |
| Giordano et al. | B cell-activating factor (BAFF) from dendritic cells, monocytes and neutrophils is required for B cell maturation and autoantibody production in SLE-like autoimmune disease | |
| Chen et al. | A gene therapy approach for treating T-cell–mediated autoimmune diseases | |
| Foster | Optimizing the translational value of animal models of glomerulonephritis: insights from recent murine prototypes | |
| Meyer zu Horste et al. | Thymic epithelium determines a spontaneous chronic neuritis in Icam1tm1JcgrNOD Mice | |
| de Mattos Barbosa et al. | TNFRSF13B genotypes control immune-mediated pathology by regulating the functions of innate B cells | |
| Liu et al. | Delayed onset of autoreactive antibody production and M2-skewed macrophages contribute to improved survival of TACI deficient MRL-Fas/Lpr mouse | |
| Peng et al. | Pathogenesis of autoimmunity in αβ T cell‐deficient lupus‐prone mice | |
| Dhande et al. | Genomics and inflammation in cardiovascular disease | |
| Thiran et al. | Sterile triggers drive joint inflammation in TNF‐and IL‐1β‐dependent mouse arthritis models | |
| Matsuda et al. | Approaches for controlling antibody-mediated allograft rejection through targeting B cells | |
| Li et al. | Mechanisms of antigen-induced reversal of CNS inflammation in experimental demyelinating disease | |
| Oeser et al. | Deletion of the G6pc2 Gene Encoding the Islet-Specific Glucose-6-Phosphatase Catalytic Subunit–Related Protein Does Not Affect the Progression or Incidence of Type 1 Diabetes in NOD/ShiLtJ Mice | |
| Baker et al. | Pre-clinical considerations in the assessment of immunogenicity for protein therapeutics | |
| Lin et al. | Transgenic expression of murine chemokine decoy receptor D6 by islets reveals the role of inflammatory CC chemokines in the development of autoimmune diabetes in NOD mice | |
| Conner et al. | A precisely humanized FCRN transgenic mouse for preclinical pharmacokinetics studies |